Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cognionics, now commonly marketed as CGX Systems, is a private neurotechnology and medical device company focused on dry-electrode electroencephalography and multimodal physiological monitoring systems. The company develops wireless EEG headsets, wearable EEG devices, physiological monitoring hardware, and related software intended for academic research, clinical research, brain-computer interface, and real-world neuroimaging applications. Its core differentiation is a proprietary dry active-electrode technology combined with low-noise electronics, active shielding, and wearable headset design. CGX appears to be commercial-stage, selling research-use systems globally and offering at least one FDA-cleared dry EEG headset product. The business is best characterized as a healthcare-adjacent neurodiagnostic and biosensing platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cognionics.